Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Outline of presentation
- Biobanking basics
- What is a biobank?
- US National Cancer Institute Epidemiologic Biorepository
- Important considerations for setting up a biobank
- Factors affecting facility design
- Other facility considerations
- Types of records maintained
- Technical issues in biobanking
- US National Cancer Institute Biorepositories & Biospecimen Research Branch
- Why is it difficult to acquire specimens and data of consistent quality?
- NCI Best Practices for Biospecimen Resources
- NCI Best Practices overview
- Web version of NCI Best Practices
- Quality management in biobanking
- Quality Management for Manuscripts
- BRISQ
- The issues which led to BRISQ development
- Potential pre-analytical variables
- BRISQ elements
- Standard PREanalytical Code (SPREC)
- SPREC-02 - biospecimen preanalytical code
- Certification and accreditation programs
- From 2016 NCI Best Practices
- CAP’s Biorepository Checklist
- CAP 3-year accreditation cycle
- International Organization for Standardization (ISO)
- Which ISO standards apply to biobanks?
- International committee developed ISO 20387
- ISO 20387:2018
- International efforts
- International efforts to develop biospecimen best practices
- International Best Practices
- Controlling variability
- Example of variability control
- Biospecimens and Biorepositories
- Multiple pre-analytical variables can affect the molecular integrity of the biospecimen
- Pre- and post-acquisition variables impact clinical and research outcomes
- HER2 assay issues: Quantifiable benefits of standardization
- Importance of biobank methods studies
- Biobanking networks
- Biobank networks and international collaborations are becoming more common
- Examples of biobank networks and governance approaches
- Qualities of well-designed biobanking networks
- A 10-year review of the 2009 network overview
- Biobanking economics and sustainability
- Economic considerations for setting up a biorepository
- Biobanking cost modeling
- JNCI Monograph: June 2011
- Developing a sustainable business model approach for the formation of human tissue biobank
- From the 2016 US NCI best practices for biospecimen resources
- Fundamental factors that drive value
- Example of an economically sustainable biobank
- Conclusions: Progress in addressing biobank economic issues
- Hot topics in international biobanking
- Critical issues in international biobanking
- Critical issues from Clinical Chemistry Q&A
- Ethical, legal, and social issues (bioethics)
- Biobanking and infectious diseases
- Historical value of scientific collections
- Preventing and curbing pandemics
- Biobanking and infectious diseases: US CDC
- Biobanking during the COVID-19 pandemic
- Necessity for new policies and practices for COVID-19 cases
- Worldwide COVID-19 pandemic
- Coronavirus, COVID-19 and biobanking
- Overview and primer on SARS-CoV-2 and COVID-19
- Nomenclature
- Biobanking in the time of COVID-19: Role of biobanks
- Biobanking in the time of COVID-19: Guidance regarding biospecimen handling
- Biobanking in the time of COVID-19: Guidance regarding biospecimen storage
- International perspectives into biobanking during the COVID-19 pandemic
- Special Issue: Countries & Topics
- The response of biobanks to COVID-19
- Diverse responses of the biobanks in indo-pacific rim region during the COVID-19 pandemic
- Biosafety guidelines for COVID-19 specimens in biobanks
- Special Case of biobanking in low-and middle-income countries
- Biobanking in Africa
- Biobank situational analysis and needs assessment survey conducted by IARC (2013/4)
- Biobank and Cohort Building Network (BCNet)
- International biobanking: Additional resources
- International Biobanking Organizations
- US NCI Biorepositories Group
- Jim Vaught, Editor-in-Chief
- References
- Thank you
Topics Covered
- Key considerations for international biobanking collaborations
- Biobanking best practices
- Factors that control biospecimen quality and variability
- Biobanking networks
- Economics of biobanking
- Biobanking for infectious diseases
- Biobanking during the COVID-19 pandemic
- Challenges encountered in low- and middle-income countries
Links
Series:
Categories:
External Links
- Slide 13 – NCI Best Practices for Biospecimen Resources
- Slide 15 – NCI Best Practices for Biospecimen Resources (web version)
- Slide 45 – International Society for Biological and Environmental Repositories ISBER
- Slide 45 – NCI
- Slide 70 – BBMRI-ERIC response to coronavirus pandemic - Resources from biobanks across Europe available for researchon SARS-CoV-2 and COVID-19
- Slide 71 – UCSF's COVID-19 Biospecimen Guidelines
- Slide 71 – CDC's Interim Laboratory Biosafety Guidelines for Handling and Processing Specimens Associated with Coronavirus Disease 2019 (COVID-19)
- Slide 72 – CDC’s testing guidance for post-mortem tissue
- Slide 73 – International Perspectives into Biobanking During the COVID-19 Pandemic
- Slide 84 – US NCI Biorepositories Group
- Slide 86 – US NCI Biorepositories & Biospecimen Research Branch
- Slide 86 – ISBER
Talk Citation
Vaught, J. (2022, June 30). International biobanking: overview of key practices and policies [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 26, 2024, from https://doi.org/10.69645/ULXD2506.Export Citation (RIS)
Publication History
Financial Disclosures
- Jim Vaught is compensated for his position as Editor-in-Chief of the journal Biopreservation & Biobanking (about $7,200 per year).
Other Talks in the Series: Tissue in Research
Transcript
Please wait while the transcript is being prepared...
0:00
Hello. I'm Jim Vaught.
Editor-in-Chief of
Biopreservation and Biobanking,
and a guest Professor at two
medical centers in China.
I'll be speaking about
international biobanking:
an overview of key
practices and policies.
0:16
Here's an outline
of my presentation.
Biobanking basics:
Best practices,
infrastructure,
quality management.
International efforts to develop
and harmonize best practices.
Controlling variability,
biobanking networks and
factors for success,
economics and sustainability,
hot topics in
international biobanking,
biobanking and
infectious diseases,
biobanking in low and
middle income countries
and additional resources
as references.
0:44
First, we'll talk about
biobanking basics:
key considerations
for internationa
biobanking collaborations.
0:52
What is a biobank?
It's an entity that
receives stores, processes
and'or disseminates
specimens such as blood,
tissue, urine, saliva,
etc., as needed.
It encompasses the
physical location
as well as the full range
of operational activities.
It can be one freezer or
free-standing entity,
virtual or part of
an institution.
It has a professional
staff and a commitment
to maintain and
preserve specimens
and records for future reference
and historical continuity.
Throughout this presentation
biobanks may also be called,
biorepositories,
biospecimen resources
or biological resource centers.
1:29
This is a photo of a
U.S. National Cancer
Institute Epidemiologic
Biorepository in Frederick,
Maryland, which is north
of Washington, D.C..
In the foreground, you
can see a number of
liquid nitrogen tanks.
In the background, what we
call mechanical freezers
or -70 or -80 degree
temperature freezers.